REG - Spire Healthcare Grp - Director/PDMR Shareholding
28/03/2024 14:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240328:nRSb7652Ia&default-theme=true
RNS Number : 7652I Spire Healthcare Group PLC 28 March 2024
28 March 2024
Spire Healthcare Group plc (the Company)
Exercise of Executive Share Plan awards
On 26 March 2024, Justin Ash and Jitesh Sodha, both Executive Directors of the
Company, exercised their vested:
· Long Term Incentive Plan awards in the Company that were granted on
25 March 2019 (the 2019 LTIP award). 2019 LTIP awards were subject to certain
performance metrics that were measured over a three-year period and full
details of the outcomes of these were reported in the Company's 2021 Annual
Report and Accounts. On vesting in March 2022, the 2019 LTIP awards were
subject to a further two-year holding period which ended in March 2024; and
· Deferred Share Bonus Plan awards that were granted on 18 March 2021
(the 2021 DSBP award). 2021 DSBP awards were subject to a three-year holding
period which ended on the third anniversary of the award being made.
Following the exercise by both Directors of their 2019 LTIP awards and 2021
DSBP awards over ordinary shares in the Company and after the satisfaction of
taxes due, both decided to retain the balance of ordinary shares as follows:
Share plan and type of award Shares vested and exercised Shares retained following satisfaction of taxes due
Justin Ash 2019 LTIP (in the form of nil-cost options) 373,263 197,829
Justin Ash 2021 DSBP (in the form of nil-cost options) 97,251 51,543
Total number of shares retained 249,372
Following the transactions, Justin Ash holds 827,640 ordinary shares in the
Company.
Share plan and type of award Shares vested and exercised Shares retained following satisfaction of taxes due
Jitesh Sodha 2019 LTIP (in the form of nil-cost options) 239,738 127,061
Jitesh Sodha 2021 DSBP (in the form of nil-cost options) 41,637 22,067
Total number of shares retained 149,128
Following the transactions, Jitesh Sodha holds 283,186 ordinary shares in the
Company.
The exercise of a vested 2019 LTIP award by John Forrest and a vested Long
Term Incentive Plan award that were granted on 18 March 2021 by Harbant Samra,
both PDMRS of the Company, are disclosed below.
Notification and public disclosure of transaction by persons discharging
managerial responsibility and persons closely associated with them
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Justinian Joseph Ash
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of nil-cost options over ordinary shares vesting under the Spire
Healthcare Group plc Long Term Incentive Plan 2014.
Following the exercise by Mr Ash of his award over 373,263 ordinary shares and
after the satisfaction of taxes due, a balance of 197,829 ordinary shares were
transferred to him which he has retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 373,263
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2024-03-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jitesh Himatlal Sodha
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of nil-cost options over ordinary shares vesting under the Spire
Healthcare Group plc Long Term Incentive Plan 2014.
Following the exercise by Mr Sodha of his award over 239,738 ordinary shares
and after the satisfaction of taxes due, a balance of 127,061 ordinary shares
were transferred to him which he has retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 239,738
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2024-03-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Justinian Joseph Ash
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of nil-cost options over ordinary shares vesting under the Spire
Healthcare Group plc Deferred Share Bonus Plan 2014.
Following the exercise by Mr Ash of his award over 97,251 ordinary shares and
after the satisfaction of taxes due, a balance of 51,543 ordinary shares were
transferred to him which he has retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 97,251
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2024-03-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jitesh Himatlal Sodha
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of nil-cost options over ordinary shares vesting under the Spire
Healthcare Group plc Deferred Share Bonus Plan 2014.
Following the exercise by Mr Sodha of his award over 41,637 ordinary shares
and after the satisfaction of taxes due, a balance of 22,067 ordinary shares
were transferred to him which he has retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 41,637
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2024-03-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name John Joseph Forrest
2 Reason for the notification
a) Position/status Chief Operating Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of nil-cost options over ordinary shares vesting under the Spire
Healthcare Group plc Long Term Incentive Plan 2014.
Following the exercise by Mr Forrest of his award over 133,525 ordinary shares
and after the satisfaction of taxes due, a balance of 70,768 ordinary shares
were sold at £2.32.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 133,525
£2.32 70,768
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2024-03-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Harbant Singh Samra
2 Reason for the notification
a) Position/status Deputy Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of nil-cost options over ordinary shares vesting under the Spire
Healthcare Group plc Long Term Incentive Plan 2014.
Following the exercise by Mr Samra of his award over 59,589 ordinary shares
and after the satisfaction of taxes due, a balance of 31,582 ordinary shares
were transferred to him which he has retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 59,589
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2024-03-26
f) Place of the transaction XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBXGDXXUDDGSIRecent news on Spire Healthcare
See all newsREG - eEnergy Group PLC Spire Healthcare Grp - Major Contract Win with Spire Healthcare
AnnouncementREG - Spire Healthcare Grp - Capital Markets Event
AnnouncementREG - Spire Healthcare Grp - Notice of AGM
AnnouncementREG - Spire Healthcare Grp - Block listing Interim Review
AnnouncementREG - Spire Healthcare Grp - Portfolio management: Spire Tunbridge Wells
Announcement